This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
New Variant Creutzfeldt-jakob Disease
Information about New Variant Creutzfeldt-jakob Disease: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of New Variant Creutzfeldt-jakob Disease
Most recent studies have shown that New Variant Creutzfeldt-jakob Disease shares some biological mechanisms with communicable-diseases, creutzfeldt-jakob-disease, dementia, disease-transmission-infectious, encephalopathies, encephalopathy-bovine-spongiform, hiv-infections, iatrogenic-disease, infective-disorder, kuru, nervousness, neurodegenerative-disorders, neuropathology-disease, plaque-amyloid, prion-diseases, scrapie, sleeplessness, sporadic-cjd, zoonoses.
Among the many pathways, these few ones have gauged particular interests from scientists studying New Variant Creutzfeldt-jakob Disease, and have been seen in publications frequently: Aging, Cell Death, Coagulation, Cognition, Donor Selection, Glycosylation, Humoral Immune Response, Immune Response, Localization, Pathogenesis, Platelet Activation, Protein Folding, Proteolysis, Quorum Sensing, Secretion, Segmentation, Translation, Transport, Tropism, Virulence
Quite a number of genes have been found to play important roles in New Variant Creutzfeldt-jakob Disease, such as ABCB6, ALB, C4BPA, CARD14, CSF2, EPHB1, ERMAP, GSS, KCNH8, LAMC2, MAPT, NLRP5, PRDX2, PRNP, SPRN, YWHAQ. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.